Error in Results and Table 1

The Original Investigation titled, “Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical Trial,”¹ published online October 14, 2021, and in the December 2021 print issue, included an error in the Results and Table 1. The numbers of non-Hispanic patients and Hispanic patients were transposed in both arms. This article has been corrected online.